[go: up one dir, main page]

HK1170673A1 - Compositions and methods for increasing blood platelet levels in humans - Google Patents

Compositions and methods for increasing blood platelet levels in humans

Info

Publication number
HK1170673A1
HK1170673A1 HK12111489.1A HK12111489A HK1170673A1 HK 1170673 A1 HK1170673 A1 HK 1170673A1 HK 12111489 A HK12111489 A HK 12111489A HK 1170673 A1 HK1170673 A1 HK 1170673A1
Authority
HK
Hong Kong
Prior art keywords
humans
compositions
methods
blood platelet
increasing blood
Prior art date
Application number
HK12111489.1A
Other languages
English (en)
Inventor
Robert E Desjardins
Rudolph Lucek
Original Assignee
Akarx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akarx Inc filed Critical Akarx Inc
Publication of HK1170673A1 publication Critical patent/HK1170673A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12111489.1A 2006-08-08 2012-11-13 Compositions and methods for increasing blood platelet levels in humans HK1170673A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83633406P 2006-08-08 2006-08-08

Publications (1)

Publication Number Publication Date
HK1170673A1 true HK1170673A1 (en) 2013-03-08

Family

ID=39082656

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111489.1A HK1170673A1 (en) 2006-08-08 2012-11-13 Compositions and methods for increasing blood platelet levels in humans

Country Status (9)

Country Link
US (2) US20080039475A1 (de)
EP (2) EP2452674B1 (de)
JP (3) JP2010500361A (de)
AU (2) AU2007284644B2 (de)
CA (1) CA2660283C (de)
ES (2) ES2452032T3 (de)
HK (1) HK1170673A1 (de)
IL (4) IL196897A (de)
WO (1) WO2008021283A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2472711C (en) * 2002-01-18 2012-03-20 Yamanouchi Pharmaceutical Co., Ltd. 2-acylaminothiazole derivative or salt thereof
US20110166112A1 (en) * 2009-08-14 2011-07-07 Eisai, Inc. Method for stimulating platelet production
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5256675A (en) * 1989-08-07 1993-10-26 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
EP0620403B1 (de) * 1993-04-08 1996-12-04 ABB Management AG Misch- und Flammenstabilisierungseinrichtung in einer Brennkammer mit Vormischverbrennung
WO1996028447A1 (fr) * 1995-03-09 1996-09-19 Kyowa Hakko Kogyo Co., Ltd. Derives de pyrrolocarbazole
AU700837B2 (en) * 1995-04-28 1999-01-14 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
EA001220B1 (ru) * 1995-06-07 2000-12-25 Глаксо Груп Лимитед Пептид или пептидомиметик, который связывается с рецептором тромбоэтина, фармацевтическая композиция и способ лечения
US5963666A (en) * 1995-08-18 1999-10-05 International Business Machines Corporation Confusion matrix mediated word prediction
WO1997014704A1 (fr) * 1995-10-17 1997-04-24 Suntory Limited Medicament contre la thrombopenie
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6187797B1 (en) * 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
AU762245B2 (en) * 1998-09-18 2003-06-19 Vertex Pharmaceuticals Incorporated Inhibitors of p38
ES2257090T3 (es) * 1998-11-17 2006-07-16 Smithkline Beecham Corporation Poliamidas ciclicas para tratar trombocitopenia.
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
EP1364949A4 (de) * 2001-02-02 2005-11-23 Takeda Pharmaceutical Jnk inhibitor
JPWO2002062775A1 (ja) * 2001-02-02 2004-06-10 山之内製薬株式会社 ２−アシルアミノチアゾール誘導体又はその塩
CA2472711C (en) * 2002-01-18 2012-03-20 Yamanouchi Pharmaceutical Co., Ltd. 2-acylaminothiazole derivative or salt thereof
JP4881559B2 (ja) * 2002-06-27 2012-02-22 ノボ・ノルデイスク・エー／エス 治療薬としてのアリールカルボニル誘導体
JP4317818B2 (ja) * 2002-09-30 2009-08-19 アステラス製薬株式会社 ２−アシルアミノチアゾール誘導体の新規な塩
US20040235834A1 (en) * 2003-03-25 2004-11-25 Farmer Luc J. Thiazoles useful as inhibitors of protein kinases
US7361658B2 (en) * 2003-07-17 2008-04-22 Astellas Pharma Inc. 2-acylaminothiazole derivative or salt thereof
ES2599529T3 (es) * 2003-08-12 2017-02-02 Shionogi & Co., Ltd. Compuestos que tienen agonismo hacia el receptor de trombopoyetina
US20070203153A1 (en) * 2005-11-08 2007-08-30 Astellas Pharma Inc. Compositions and methods for treating thrombocytopenia

Also Published As

Publication number Publication date
ES2452032T3 (es) 2014-03-31
AU2007284644A1 (en) 2008-02-21
IL196897A (en) 2015-08-31
US20080039475A1 (en) 2008-02-14
AU2011253775B2 (en) 2014-02-13
IL240323A (en) 2016-05-31
EP2056826A2 (de) 2009-05-13
AU2011253775A1 (en) 2011-12-22
JP2015221806A (ja) 2015-12-10
IL245911A0 (en) 2016-07-31
EP2452674A2 (de) 2012-05-16
JP6258264B2 (ja) 2018-01-10
CA2660283A1 (en) 2008-02-21
CA2660283C (en) 2014-11-18
EP2056826B1 (de) 2014-01-08
ES2470333T3 (es) 2014-06-23
IL196897A0 (en) 2011-08-01
WO2008021283A2 (en) 2008-02-21
US20110224226A1 (en) 2011-09-15
EP2452674A3 (de) 2012-05-30
WO2008021283A3 (en) 2008-12-11
JP2010500361A (ja) 2010-01-07
JP2013047257A (ja) 2013-03-07
IL240323A0 (en) 2015-09-24
IL240322A0 (en) 2015-09-24
EP2056826A4 (de) 2009-09-09
AU2007284644B2 (en) 2011-09-01
EP2452674B1 (de) 2014-03-26

Similar Documents

Publication Publication Date Title
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
HK1137670A1 (en) Compositions and methods for arthrodetic procedures
ZA201001300B (en) Antigen-asjuvant compositions and methods
EP2101731A4 (de) Verfahren und zusammensetzungen mit endoxifen
IL196465A0 (en) Compositions and methods for the treatment of mucositis
HK1125868A1 (en) Compositions and methods for treating bone
EP2046936A4 (de) Biozide zusammensetzungen und verfahren
EP2064300A4 (de) Gewebehaftzusammensetzungen und verfahren dafür
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2109673A4 (de) Verfahren und vorrichtung für verstärkte protein-expression und -reinigung
GB0721291D0 (en) Methods and compositions
GB0617171D0 (en) Novel compositions and methods
EP2076281A4 (de) Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren
IL196411A0 (en) Anti-cocaine compositions and treatment
PL2061458T3 (pl) Kompozycje topiramatu i sposoby ich stosowania
ZA200707490B (en) Methods and compositions for modulatiing vascular integrity
GB0719526D0 (en) Compositions and methods
EP2029132A4 (de) Anti-histaminzusammensetzungen und ihre verwendung
HK1129596A1 (en) Methods and compositions for treating disease
IL245911A0 (en) Compositions and methods for increasing the level of blood platelets in humans
PL2132251T3 (pl) Kompozycja i sposób
GB0625208D0 (en) Composition and method
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0718271D0 (en) Lubricant formulations and methods
GB0600261D0 (en) Composition and method